This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
168
Mean Change From Baseline in Pruritus Symptoms, as Measured by the 24-hour Average Pruritus Visual Analogue Scale (VAS) Score
Responses were measured on a 100-mm Visual Analogue Scale (VAS), where the left endpoint was marked "no itch" (0 mm) and in the right endpoint was marked "worst imaginable itch" (100 mm).
Time frame: 56 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Vanda Investigational Site
Encinitas, California, United States
Vanda Investigational Site
Encino, California, United States
Vanda Investigational Site
Lomita, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
Miami, Florida, United States
Vanda Investigational Site
Miami, Florida, United States
Vanda Investigational Site
Ormond Beach, Florida, United States
Vanda Investigational Site
Columbus, Georgia, United States
Vanda Investigational Site
Plainfield, Indiana, United States
...and 18 more locations